Bank of New York Mellon’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $215K | Sell |
|
|||||
|
2022
Q4 | $280K | Sell |
|
|||||
|
2022
Q3 | $514K | Buy |
|
|||||
|
2022
Q2 | $538K | Buy |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $1.53M | Sell |
|
|||||
|
2021
Q3 | $2.04M | Buy |
|
|||||
|
2021
Q2 | $2.02M | Sell |
|
|||||
|
2021
Q1 | $2.22M | Sell |
|
|||||
|
2020
Q4 | $2.03M | Buy |
|
|||||
|
2020
Q3 | $1.68M | Sell |
|
|||||
|
2020
Q2 | $1.98M | Buy |
|
|||||
|
2020
Q1 | $451K | Buy |
|
|||||
|
2019
Q4 | $224K | Hold |
|
|||||
|
2019
Q3 | $76K | Buy |
|
|||||
|
2019
Q2 | $183K | Buy |
|
|||||
|
2019
Q1 | $49K | Sell |
|
|||||
|
2018
Q4 | $51K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $248K | Buy |
|
|||||
|
2017
Q4 | $293K | Buy |
|
|||||
|
2017
Q3 | $171K | Sell |
|
|||||
|
2017
Q2 | $193K | Buy |
|